Trials / Unknown
UnknownNCT06155734
Fluorescence Guided Minimally-Invasive Resection Of Abdominal Paragangliomas Using Indocyanine Green
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 6 (estimated)
- Sponsor
- Leiden University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is exploring whether it's possible to detect paragangliomas (a rare type of tumor) during minimally invasive surgery by using a technique called near-infrared fluorescence imaging, guided by a substance called indocyanine green (ICG). The goal is to see if this method can help surgeons identify and treat paragangliomas more accurately and during minimally invasive procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluorescence guided identification using indocyanine green | During minimally invasive surgery using intravenous administration of indocyanine green (ICG) near-infrared fluorescence imaging will be applied to identify and treat paragangliomas |
Timeline
- Start date
- 2023-11-11
- Primary completion
- 2023-12-30
- Completion
- 2024-02-20
- First posted
- 2023-12-04
- Last updated
- 2023-12-04
Locations
1 site across 1 country: Netherlands
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06155734. Inclusion in this directory is not an endorsement.